Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma

Published:2020 Issue:1 Volume:83 Page:61
ISSN:1738-3536
Container-title:Tuberculosis and Respiratory Diseases
language:en
Short-container-title:Tuberc Respir Dis

Author:

Kang Byung Ju¹^ORCID,Ra Seung Won¹,Lee Kyusang²,Lim Soyeoun³,Son So Hee²,Ahn Jong-Joon¹^ORCID,Kim Byung Chul²^ORCID

Affiliation:

1. Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

2. Liquid Biopsy and Precision Medicine Division, Clinomics Inc., Ulsan, Korea.

3. Department of Radiology, Ulsan University Hospital, Ulsan, Korea.

Publisher

The Korean Academy of Tuberculosis and Respiratory Diseases

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Link

https://synapse.koreamed.org/pdf/10.4046/trd.2019.0048

Reference23 articles.

1. Global cancer statistics, 2012

2. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer

3. International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women

4. Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

5. Circulating Tumor Cells: A Multifunctional Biomarker

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters;Cancers;2023-11-11

2. Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents;The Oncologist;2023-08-07

3. Circulating tumour cells for early detection of clinically relevant cancer;Nature Reviews Clinical Oncology;2023-06-02

4. Circulating Tumor Cells as a Predictive Biomarker in Resectable Lung Cancer: A Systematic Review and Meta-Analysis;Cancers;2022-12-12

5. A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma;Annals of Translational Medicine;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3